FDA Approved Products

99 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LaunchClear all
YUVEZZI
carbachol and brimonidine tartrate
Launch
OPHTHALMIC · SOLUTION/DROPS
2026
NDA
0/100
ZEGFROVY
sunvozertinib
Launch
ORAL · TABLET
2025
SMNDA
0/100
ZOLYMBUS
bimatoprost
Launch
Thea Pharma
OPHTHALMIC · GEL
2025
NDA
0/100
← PreviousPage 5 of 5